Back

Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?

European Heart Journal

27 January 2021
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Pharmacology and Pharmacotherapy

Contributors

Mattia Lunardi
Mattia Lunardi

Author

IRCCS Foundation Agostino Gemelli University Hospital Rome , Italy

Yoshinobu Onuma
Yoshinobu Onuma

Author

Patrick W Serruys
Patrick W Serruys

Author

University of Galway Galway , Ireland

You may be interested in
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis Explore sponsored resources